BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31526532)

  • 1. Disparities of HIV risk and PrEP use among transgender women of color in South Florida.
    Holder CL; Perez-Gilbe HR; Fajardo FJ; Garcia S; Cyrus E
    J Natl Med Assoc; 2019 Dec; 111(6):625-632. PubMed ID: 31526532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017.
    Iniesta C; Álvarez-Del Arco D; García-Sousa LM; Alejos B; Díaz A; Sanz N; Garrido J; Meulbroek M; Pujol F; Moreno S; Fuster-Ruiz de Apocada MJ; Coll P; Antela A; Del Romero J; Ayerdi O; Riera M; Hernández J; Del Amo J
    PLoS One; 2018; 13(10):e0204738. PubMed ID: 30339690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial.
    Deutsch MB; Glidden DV; Sevelius J; Keatley J; McMahan V; Guanira J; Kallas EG; Chariyalertsak S; Grant RM;
    Lancet HIV; 2015 Dec; 2(12):e512-9. PubMed ID: 26614965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
    Hoagland B; De Boni RB; Moreira RI; Madruga JV; Kallas EG; Goulart SP; Cerqueira N; Torres TS; Luz PM; Fernandes NM; Liu AY; Grinsztejn B; Veloso VG;
    AIDS Behav; 2017 May; 21(5):1278-1287. PubMed ID: 27531461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEP awareness and use among reproductive age women in Miami, Florida.
    Nogueira NF; Luisi N; Salazar AS; Cherenack EM; Raccamarich P; Klatt NR; Jones DL; Alcaide ML
    PLoS One; 2023; 18(6):e0286071. PubMed ID: 37285343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlates of PrEP Indication in a Multi-Site Cohort of Young HIV-Uninfected Transgender Women.
    Kuhns LM; Reisner SL; Mimiaga MJ; Gayles T; Shelendich M; Garofalo R
    AIDS Behav; 2016 Jul; 20(7):1470-7. PubMed ID: 26336946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practices of receptive and insertive anal sex among transgender women in relation to partner types, sociocultural factors, and background variables.
    Nemoto T; Bödeker B; Iwamoto M; Sakata M
    AIDS Care; 2014 Apr; 26(4):434-40. PubMed ID: 24160715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Social Support in HIV Testing and PrEP Awareness among Young Black Men and Transgender Women Who Have Sex with Men or Transgender Women.
    Lelutiu-Weinberger C; Wilton L; Koblin BA; Hoover DR; Hirshfield S; Chiasson MA; Nandi V; Usher D; Frye V
    J Urban Health; 2020 Oct; 97(5):715-727. PubMed ID: 31898199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
    Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
    J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    Ongwandee S; Lertpiriyasuwat C; Khawcharoenporn T; Chetchotisak P; Thiansukhon E; Leerattanapetch N; Leungwaranan B; Manopaiboon C; Phoorisri T; Visavakum P; Jetsawang B; Poolsawat M; Nookhai S; Vasanti-Uppapokakorn M; Karuchit S; Kittinunvorakoon C; Mock P; Prybylski D; Sukkul AC; Roels T; Martin M
    PLoS One; 2018; 13(7):e0201171. PubMed ID: 30044867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.
    Yan L; Yan Z; Wilson E; Arayasirikul S; Lin J; Yan H; McFarland W
    AIDS Behav; 2021 Mar; 25(3):866-874. PubMed ID: 32989576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis: awareness, acceptability and risk compensation behaviour among men who have sex with men and the transgender population.
    Uthappa CK; Allam RR; Pant R; Pal S; Dinaker M; Oruganti G; Yeldandi VV
    HIV Med; 2018 Apr; 19(4):243-251. PubMed ID: 29178158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrEP awareness among people living with HIV in Florida: Florida Cohort study.
    Algarin AB; Zhou Z; Canidate S; Gebru NM; Krieger JL; Neil JM; Cook RL; Ibañez GE
    AIDS Care; 2021 Apr; 33(4):428-433. PubMed ID: 31960703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Pre-exposure Prophylaxis Indication and Readiness Among HIV-Uninfected Transgender Women in Ho Chi Minh City, Vietnam.
    Oldenburg CE; Le B; Toan T; Thien DD; Huyen HT; Friedman MR; Stall R; Colby D
    AIDS Behav; 2016 Dec; 20(Suppl 3):365-370. PubMed ID: 27435073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of HIV Pre- and Postexposure Prophylaxis Among a Web-Based Sample of HIV-Negative and Unknown Status Cisgender and Transgender Sexual Minority Men: Cross-sectional Study.
    John SA; Sizemore KM; Jimenez RH; Jones SS; Petroll AE; Rendina HJ
    JMIR Public Health Surveill; 2022 Dec; 8(12):e31237. PubMed ID: 36306518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics Associated with Pre-Exposure Prophylaxis Discussion and Use Among Transgender Women Without HIV Infection - National HIV Behavioral Surveillance Among Transgender Women, Seven Urban Areas, United States, 2019-2020.
    Morris E; Teplinskaya A; Olansky E; Rinderle JK; Chapin-Bardales J;
    MMWR Suppl; 2024 Jan; 73(1):9-20. PubMed ID: 38261546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of Daily Use of Free Oral Pre-exposure Prophylaxis (PrEP) Among Transgender Women Sex Workers in Shenyang, China.
    Wang Z; Lau JTF; Yang X; Cai Y; Gross DL; Ma T; Liu Y
    AIDS Behav; 2017 Dec; 21(12):3287-3298. PubMed ID: 28752354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing Urban African American Women's Readiness for Pre-exposure Prophylaxis: A Pilot Study of the Women Prepping for PrEp Plus Program (WP3+).
    Wyatt GE; Norwood-Scott E; Cooley-Strickland M; Zhang M; Smith-Clapham A; Jordan W; Liu H; Hamilton AB
    Womens Health Issues; 2024; 34(3):241-249. PubMed ID: 38267337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.